ACAD
31.22
0.00
0.00%
AEMD
0.26
+0.00
+1.38%
APRI
1.33
0.00
0.00%
ARNA
4.56
0.00
0.00%
ATEC
1.3
0.00
0.00%
CFN
59.56
0.00
0.00%
CNAT
5.79
0.00
0.00%
CRXM
0.21
+0.01
+6.01%
CYTX
0.48
0.00
0.00%
DXCM
60.59
0.00
0.00%
GNMK
13.11
0.00
0.00%
HALO
14.15
0.00
0.00%
ILMN
197.86
0.00
0.00%
INNV
0.2
+0.00
+0.05%
INO
8.5
0.00
0.00%
ISCO
0.06
0.00
-4.17%
ISIS
68.58
0.00
0.00%
LGND
57.42
0.00
0.00%
LPTN
2.89
0.00
0.00%
MBVX
1.15
+0.04
+3.60%
MEIP
3.72
0.00
0.00%
MNOV
3.79
0.00
0.00%
MRTX
20.46
0.00
0.00%
MSTX
0.45
0.00
0.00%
NBIX
33.39
0.00
0.00%
NUVA
46.47
0.00
0.00%
ONCS
0.39
-0.01
-2.41%
ONVO
6.49
0.00
0.00%
OREX
5.49
0.00
0.00%
OTIC
31.73
0.00
0.00%
QDEL
24.36
0.00
0.00%
RCPT
113.07
0.00
0.00%
RGLS
17.66
0.00
0.00%
RMD
63.32
0.00
0.00%
SCIE
0.01
+0.00
+5.04%
SPHS
0.44
0.00
0.00%
SRNE
10.39
0.00
0.00%
TROV
5.85
0.00
0.00%
VICL
1.03
0.00
0.00%
VOLC
17.96
0.00
0.00%
ZGNX
1.38
0.00
0.00%
Home » Events

San Diego Biotech Discussion Group Biotalk

Submitted by on July 15, 2009 – 1:12 pm

“Tumor Targeting with Nanoparticles”
Marit Piacente, DVM – Head of Preclinical Development, Abraxis

July 29, 2009
5:30 – 8:00 pm
(Announcements begin at 6:30 pm)

AT SORRENTO SUMMIT

[[Click here for more information.]]

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


four + = 13